Status:
TERMINATED
Seasonal Allergic Rhinitis and Driving Ability
Lead Sponsor:
Utrecht Institute for Pharmaceutical Sciences
Collaborating Sponsors:
UCB Pharma
Conditions:
Seasonal Allergic Rhinitis
Eligibility:
All Genders
21-50 years
Phase:
PHASE4
Brief Summary
On-the-road driving performance of untreated seasonal allergic rhinitis patients during the allergic season (exposed) is compared to driving performance outside the allergic season (in winter, not-exp...
Detailed Description
This study was set-up to examine whether untreated seasonal allergic rhinitis has an effect on driving ability. In addition to the driving tests, patients perform a memory test in the laboratory.
Eligibility Criteria
Inclusion
- outpatients with seasonal allergic rhinitis
- a valid driver's licence
- written informed consent
- a T5SS score \>8 during the allergic season and \<3 in winter
Exclusion
- use of medication or medical conditions that are known to affect driving ability
- associated ENT disease or asthma
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00223587
Start Date
September 1 2004
End Date
January 1 2008
Last Update
April 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Utrecht Institute for Pharmaceutical Sciences
Utrecht, Netherlands, 3508TB